Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.05 USD | +2.52% | +5.34% | +1.96% |
May. 08 | Stifel Cuts Price Target on Astrana Health to $45 From $50, Maintains Buy Rating | MT |
May. 07 | Transcript : Astrana Health, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 1.77B | Sales 2025 * | 2.13B | Capitalization | 1.81B |
---|---|---|---|---|---|
Net income 2024 * | 74M | Net income 2025 * | 91M | EV / Sales 2024 * | 0.98 x |
Net cash position 2024 * | 77.7M | Net cash position 2025 * | 173M | EV / Sales 2025 * | 0.77 x |
P/E ratio 2024 * |
25.8
x | P/E ratio 2025 * |
21.5
x | Employees | 1,800 |
Yield 2024 * |
0.33% | Yield 2025 * |
0.41% | Free-Float | 64.74% |
Latest transcript on Astrana Health, Inc.
1 day | +2.52% | ||
1 week | +5.34% | ||
Current month | +5.11% | ||
1 month | -8.25% | ||
3 months | +4.78% | ||
6 months | +28.24% | ||
Current year | +1.96% |
Managers | Title | Age | Since |
---|---|---|---|
Kenneth Sim
FOU | Founder | 70 | 85-10-31 |
Brandon Sim
CEO | Chief Executive Officer | 30 | 19-05-31 |
Thomas Lam
FOU | Founder | 74 | 85-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Li Dai
BRD | Director/Board Member | 62 | 21-12-30 |
Director/Board Member | 67 | 17-12-07 | |
Director/Board Member | 67 | 19-09-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 0 M€ | +3.90% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 38.09 | +0.42% | 158,669 |
24-05-07 | 37.93 | -1.02% | 125,527 |
24-05-06 | 38.32 | +2.30% | 106,286 |
24-05-03 | 37.46 | +1.05% | 106,977 |
24-05-02 | 37.07 | -0.48% | 114,734 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.96% | 1.81B | |
+18.92% | 81.04B | |
-29.48% | 68.93B | |
+9.65% | 29.59B | |
-0.14% | 17.24B | |
-9.30% | 16.99B | |
+0.20% | 15.12B | |
+5.25% | 13.09B | |
+68.96% | 12B | |
-2.88% | 11.94B |
- Stock Market
- Equities
- ASTH Stock